We used R software to calculate the difference in AKR1C1 expression between normal samples and tumor samples for each tumor and used non-paired Wilcoxon rank sum and signed rank tests to determine significance, as shown in Figure 3A. This evidence concerns the gene AKR1C1 and neoplasm.